Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents

References

• Patel SS, Picha KM Structure and function of hexameric helicases. Annu Rev Biochem. 2000, 69, 651–697.
   PubMed Web of Science ®Google Scholar
• Ellis NA, Groden J, Ye TZ, et al. The bloom’s syndrome gene product is homologous to RecQ helicases. Cell 1995, 83, 655–666.
   PubMed Web of Science ®Google Scholar
• Karow JK, Chakraverty RK, Hickson ID The Bloom’s syndrome gene product is a 3ʹ-5ʹ DNA helicase. J Bio Chem. 1997, 272, 30611–30614.
   PubMed Web of Science ®Google Scholar
• Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner’s syndrome gene. Science 1996, 272, 258–262.
   PubMed Web of Science ®Google Scholar
• Shen JC, Gray MD, Oshima J, et al. Characterization of Werner syndrome protein DNA helicase activity: directionality, substrate dependence and stimulation by replication protein A. Nucleic Acids Res. 1998, 26, 2879–2885.
   PubMed Web of Science ®Google Scholar
• Gray MD, Shen JC, Kamath-Loeb AS, et al. The Werner syndrome protein is a DNA helicase. Nat Genet. 1997, 17, 100–103.
   PubMed Web of Science ®Google Scholar
• Nakura J, Ye L, Morishima A, et al. Helicases and aging. Cell Mol Life Sci. 2000, 57, 716–730.
   PubMed Web of Science ®Google Scholar
• Cunniff C, Bassetti JA, Ellis NA Bloom’s syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition. Mol Syndromol. 2017, 8, 4–23.
   PubMed Web of Science ®Google Scholar
• Luo J Wrn protein and Werner syndrome. N Am J Med Sci (Boston) 2010, 3, 205–207.
   PubMedGoogle Scholar
• Snijder EJ, Bredenbeek PJ, Dobbe JC, et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 2003, 331, 991–1004.
   PubMed Web of Science ®Google Scholar
• Gorbalenya AE, Enjuanes L, Ziebuhr J, et al. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006, 117, 17–37.
   PubMed Web of Science ®Google Scholar
• Ivanov KA, Thiel V, Dobbe JC, et al. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase. J Virol. 2004, 78, 5619–5632.
   PubMed Web of Science ®Google Scholar
• Gorbalenya AE, Snijder EJ, Spaan WJ severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J Virol. 2004, 78, 7863–7866.
   PubMed Web of Science ®Google Scholar
• Frick DN Step-by-step progress toward understanding the hepatitis C virus RNA helicase. Hepatology 2006, 43, 1392–1395.
   PubMedGoogle Scholar
• Frick DN Helicases as antiviral drug targets. Drug News Perspect 2003, 16, 355–362.
   PubMed Web of Science ®Google Scholar
• Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300, 1394–1399.
   PubMed Web of Science ®Google Scholar
• Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003, 300, 1399–1404.
   PubMed Web of Science ®Google Scholar
• Herold J, Siddell S, Ziebuhr J Characterization of coronavirus RNA polymerase gene products. Methods Enzymol. 1996, 275, 68–89.
   PubMed Web of Science ®Google Scholar
• Thiel V, Ivanov KA, Putics A, et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol. 2003, 84, 2305–2315.
   PubMed Web of Science ®Google Scholar
• Ziebuhr J The coronavirus replicase. Curr Top Microbiol Immunol. 2005, 287, 57–94.
   PubMed Web of Science ®Google Scholar
• Ziebuhr J Molecular biology of severe scute respiratory syndrome coronavirus. Curr Opin Microbiol 2004, 7, 412–419.
   PubMed Web of Science ®Google Scholar
• Putics A, Filipowicz W, Hall J, et al. ADP-ribose-1”-monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture. J Virol. 2005, 79, 12721–12731.
   PubMed Web of Science ®Google Scholar
• Perlman S, Netland J Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 2009, 7, 439–450.
   PubMed Web of Science ®Google Scholar
• Navas-Martin SR, Weiss S Coronavirus replication and pathogenesis: implications for the recent outbreak of Severe Acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol. 2004, 10, 75–85.
   PubMed Web of Science ®Google Scholar
• Harcourt BH, Jukneliene D, Kanjanahaluethai A, et al. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol. 2004, 78, 13600–13612.
   PubMed Web of Science ®Google Scholar
• Ziebuhr J, Snijder EJ, Gorbalenya AE Virus-encoded proteinases and proteolytic processing in the nidovirales. J Gen Virol. 2000, 81, 853–879.
   PubMed Web of Science ®Google Scholar
• Fan K, Wei P, Feng Q, et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem. 2004, 279, 1637–1642.
   PubMed Web of Science ®Google Scholar
• Anand K, Ziebuhr J, Wadhwani P, et al. Coronavirus main proteinase (3Clpro) structure: basis for design of anti-SARS drugs. Science 2003, 300, 1763–1767.
   PubMed Web of Science ®Google Scholar
• Yang H, Yang M, Ding Y, et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A 2003, 100, 13190–13195.
   PubMed Web of Science ®Google Scholar
• Bernini A, Spiga O, Venditti V, et al. Tertiary structure prediction of SARS coronavirus helicase. Biochem Biophys Res Commun. 2006, 343, 1101–1104.
   PubMed Web of Science ®Google Scholar
• Minskaia E, Hertzig T, Gorbalenya AE, et al. Discovery of an RNA virus 3ʹ->5ʹ exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci U S A 2006, 103, 5108–5113.
   PubMed Web of Science ®Google Scholar
• Ricagno S, Egloff MP, Ulferts R, et al. Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family. Proc Natl Acad Sci U S A 2006, 103, 11892–11897.
   PubMed Web of Science ®Google Scholar
• Bhardwaj K, Sun J, Holzenburg A, et al. RNA recognition and cleavage by the SARS coronavirus endoribonuclease. J Mol Biol. 2006, 361, 243–256.
   PubMed Web of Science ®Google Scholar
• Sawicki SG, Sawicki DL, Siddell SG A contemporary view of coronavirus transcription. J Virol. 2007, 81, 20–29.
   PubMed Web of Science ®Google Scholar
• Kumar V, Jung YS, Liang PH Anti-SARS coronavirus agents: a patent review (2008 – present). Expert Opin Therap Patents 2013, 23, 1337–1348.
   PubMed Web of Science ®Google Scholar
• Yan L, Ge J, Zheng L, et al. Cryo-Em structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis. Cell 2021, 184, 184–193 e110.
   PubMed Web of Science ®Google Scholar
• von Brunn A, Teepe C, Simpson JC, et al. Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome. PLoS One 2007, 2, e459.
   PubMed Web of Science ®Google Scholar
• Pan J, Peng X, Gao Y, et al. Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication. PLoS One 2008, 3, e3299.
   PubMed Web of Science ®Google Scholar
• Prentice E, McAuliffe J, Lu X, et al. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J Virol. 2004, 78, 9977–9986.
   PubMed Web of Science ®Google Scholar
• Imbert I, Snijder EJ, Dimitrova M, et al. The SARS-coronavirus plnc domain of nsp3 as a replication/transcription scaffolding protein. Virus Res. 2008, 133, 136–148.
   PubMed Web of Science ®Google Scholar
• Adedeji AO, Marchand B, Te Velthuis AJ, et al. Mechanism of nucleic acid unwinding by SARS-CoV helicase. PLoS One 2012, 7, e36521.
   PubMed Web of Science ®Google Scholar
• Romano M, Ruggiero A, Squeglia F, et al. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells 2020, 9. 9
   Web of Science ®Google Scholar
• Yan L, Zhang Y, Ge J, et al. Architecture of a SARS-CoV-2 mini replication and transcription complex. Nat Commun. 2020, 11, 5874.
   PubMed Web of Science ®Google Scholar
• Xia H, Cao Z, Xie X, et al. Evasion of type i interferon by SARS-CoV-2. Cell Rep. 2020, 33, 108234.
   PubMed Web of Science ®Google Scholar
• Appelberg S, Gupta S, Svensson Akusjarvi S, et al. Dysregulation in akt/mtor/hif-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect. 2020, 9, 1748–1760.
   PubMed Web of Science ®Google Scholar
• Yuen CK, Lam JY, Wong WM, et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect. 2020, 9, 1418–1428.
   PubMed Web of Science ®Google Scholar
• Singleton MR, Wigley DB Modularity and specialization in superfamily 1 and 2 helicases. J Bacteriol. 2002, 184, 1819–1826.
   PubMed Web of Science ®Google Scholar
• Gorbalenya AE, Koonin EV Viral proteins containing the purine NTP-binding sequence pattern. Nucleic Acids Res. 1989, 17, 8413–8440.
   PubMed Web of Science ®Google Scholar
• Chen J, Malone B, Llewellyn E, et al. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex. Cell 2020, 182, 1560–1573 e1513.
   PubMed Web of Science ®Google Scholar
• Lee NR, Kwon HM, Park K, et al. Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsp13. Nucleic Acids Res. 2010, 38, 7626–7636.
   PubMed Web of Science ®Google Scholar
• Tanner JA, Watt RM, Chai YB, et al. The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5ʹ to 3ʹ viral helicases. J Biol Chem 2003, 278, 39578–39582.
   PubMed Web of Science ®Google Scholar
• Flores MJ, Sanchez N, Michel B A fork-clearing role for uvrd. Mol Microbiol. 2005, 57, 1664–1675.
   PubMed Web of Science ®Google Scholar
• Hao W, Wojdyla JA, Zhao R, et al. Crystal structure of Middle East respiratory syndrome coronavirus helicase. PLoS Pathog 2017, 13, e1006474.
   PubMed Web of Science ®Google Scholar
• Jia Z, Yan L, Ren Z, et al. Delicate structural coordination of the severe acute respiratory syndrome coronavirus nsp13 upon ATP hydrolysis. Nucleic Acids Res. 2019, 47, 6538–6550.
   PubMed Web of Science ®Google Scholar
• Seybert A, Posthuma CC, van Dinten LC, et al. A complex zinc finger controls the enzymatic activities of nidovirus helicases. J Virol. 2005, 79, 696–704.
   PubMed Web of Science ®Google Scholar
• van Dinten LC, van Tol H, Gorbalenya AE, et al. The predicted metal-binding region of the arterivirus helicase protein is involved in subgenomic mRNA synthesis, genome replication, and virion biogenesis. J Virol. 2000, 74, 5213–5223.
   PubMed Web of Science ®Google Scholar
• DeLano WL An open-source molecular graphics tool. Ccp4 Newsl Protein Crystallogr 2002, 40, 82–92.
   Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273.
   PubMed Web of Science ®Google Scholar
• Boni MF, Lemey P, Jiang X, et al. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nature Microbiol. 2020, 5, 1408–1417.
   PubMed Web of Science ®Google Scholar
• Neogi U, Hill KJ, Ambikan AT, et al. Feasibility of known RNA polymerase inhibitors as anti-SARS-CoV-2 drugs. Pathogens 2020, 9. 9
   Web of Science ®Google Scholar
• Yu G, Lam TT, Zhu H, et al. Two methods for mapping and visualizing associated data on phylogeny using ggtree. Mol Biol Evol. 2018, 35, 3041–3043.
   PubMed Web of Science ®Google Scholar
• Team RC R: a language and environment for statistical computing. R foundation for statistical computing, vienna, austria. Isbn 3–900051–07–0. http://www.R-project.org 2013.
   Google Scholar
• Adedeji AO, Singh K, Calcaterra NE, et al. Severe Acute Respiratory Syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrob Agents Chemother. 2012, 56, 4718–4728.
   PubMed Web of Science ®Google Scholar
• Adedeji AO, Singh K, Kassim A, et al. Evaluation of SSYA10–001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrob Agents Chemother. 2014, 58, 4894–4898.
   PubMed Web of Science ®Google Scholar
• Backman TW, Cao Y, Girke T Chemmine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res 2011, 39, W486–491.
   PubMed Web of Science ®Google Scholar
• Rogers DJ, Tanimoto TT A computer program for classifying plants. Science 1960, 132, 1115–1118.
   PubMed Web of Science ®Google Scholar
• O’Boyle NM, Banck M, James CA, et al. Open BABEL: an open chemical toolbox. J Chem inform. 2011, 3, 33.
   Google Scholar
• Cao Y, Charisi A, Cheng LC, et al. Chemminer: a compound mining framework for R. Bioinformatics 2008, 24, 1733–1734.
   PubMed Web of Science ®Google Scholar
• Yu MS, Lee J, Lee JM, et al. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsp13. Bioorg Med Chem Lett. 2012, 22, 4049–4054.
   PubMed Web of Science ®Google Scholar
• Keum YS, Jeong YJ Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target. Biochem Pharmacol. 2012, 84, 1351–1358.
   PubMed Web of Science ®Google Scholar
• Di Santo R, Fermeglia M, Ferrone M, et al. Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors. J Med Chem. 2005, 48, 6304–6314.
   PubMed Web of Science ®Google Scholar
• Lee JM, Cho JB, Ahn HC, et al. A novel chemical compound for inhibition of SARS coronavirus helicase. J Microbiol Biotechnol. 2017, 27, 2070–2073.
   PubMed Web of Science ®Google Scholar
• Cho JB, Lee JM, Ahn HC, et al. Identification of a novel small molecule inhibitor against SARS coronavirus helicase. J Microbiol Biotechnol. 2015, 25, 2007–2010.
   PubMed Web of Science ®Google Scholar
• Tanner JA, Zheng BJ, Zhou J, et al. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem Biol. 2005, 12, 303–311.
   PubMedGoogle Scholar
• Yang N, Tanner JA, Wang Z, et al. Inhibition of SARS coronavirus helicase by bismuth complexes. Chem Commun (Camb) 2007, 4413–4415.
   PubMed Web of Science ®Google Scholar
• Lee C, Lee JM, Lee NR, et al. Investigation of the pharmacophore space of severe acute respiratory syndrome coronavirus (SARS-CoV) ntpase/helicase by dihydroxychromone derivatives. Bioorg Med Chem Lett. 2009, 19, 4538–4541.
   PubMed Web of Science ®Google Scholar
• Shum KT, Tanner JA Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. Chembiochem. 2008, 9, 3037–3045.
   PubMed Web of Science ®Google Scholar
• Yang N, Tanner JA, Zheng BJ, et al. Bismuth complexes inhibit the SARS coronavirus. Angew Chem Int Ed Eng. 2007, 46, 6464–6468.
   PubMed Web of Science ®Google Scholar
• Lee C, Lee JM, Lee NR, et al. Aryl diketoacids (adk) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase. Bioorg Med Chem Lett. 2009, 19, 1636–1638.
   PubMed Web of Science ®Google Scholar
• Lee JM, Cho JB, Ahn HC, et al. Selective inhibition of enzymatic activities of severe acute respiratory syndrome coronavirus helicase with a thioxopyrimidine derivative. Bull Korean Chem Soc. 2016, 37, 2066–2068.
   PubMed Web of Science ®Google Scholar
• Jang KJ, Lee NR, Yeo WS, et al. Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase. Biochem Biophys Res Commun. 2008, 366, 738–744.
   PubMed Web of Science ®Google Scholar
• Shu T, Huang M, Wu D, et al. SARS-coronavirus-2 nsp13 possesses ntpase and RNA helicase activities that can be inhibited by bismuth salts. Virol Sin. 2020, 35, 321–329.
   PubMed Web of Science ®Google Scholar
• Chono K, Katsumata K, Kontani T, et al. Asp2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. J Antimicrob Chemother. 2010, 65, 1733–1741.
   PubMed Web of Science ®Google Scholar
• Katsumata K, Weinberg A, Chono K, et al. Susceptibility of herpes simplex virus isolated from genital herpes lesions to Asp2151, a novel helicase-primase inhibitor. Antimicrob Agents Chemother. 2012, 56, 3587–3591.
   PubMed Web of Science ®Google Scholar
• Tyring S, Wald A, Zadeikis N, et al. Asp2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study. J Infect Dis. 2012, 205, 1100–1110.
   PubMed Web of Science ®Google Scholar
• Wald A, Corey L, Timmler B, et al. Helicase-primase inhibitor pritelivir for HSV-2 infection. N Eng J Med. 2014, 370, 201–210.
   PubMed Web of Science ®Google Scholar
• Aicuris. A double-blind randomized placebo controlled dose-finding trial to investigate different doses of a new antiviral drug in subjects with genital HSV type 2 infection. Clin trial. 2011; NCT01047540. available from: http://clinicaltrials.Gov/ct2/results?Term=nct01047540&
   Google Scholar
• Weller SK, Kuchta RD The DNA helicase-primase complex as a target for herpes viral infection. Expert Opin Ther Targets 2013, 17, 1119–1132.
   PubMed Web of Science ®Google Scholar
• Datta A, Brosh RM Jr. New insights into DNA helicases as druggable targets for cancer therapy. Front Mol Biosci. 2018, 5, 59.
   PubMed Web of Science ®Google Scholar
• Belon CA, Frick DN Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C. Future Virol. 2009, 4, 277–293.
   PubMed Web of Science ®Google Scholar
• Guo F, Stanevich V, Wlodarchak N, et al. Structural basis of PP2A activation by PTPA, an ATP-dependent activation chaperone. Cell Res. 2014, 24, 190–203.
   PubMed Web of Science ®Google Scholar
• Beese LS, Steitz TA Structural basis for the 3ʹ-5ʹ exonuclease activity of Escherichia coli DNA polymerase i: a two metal ion mechanism. Embo J. 1991, 10, 25–33.
   PubMed Web of Science ®Google Scholar
• Copeland WC The mitochondrial DNA polymerase in health and disease. Subcell Biochem. 2010, 50, 211–222.
   PubMedGoogle Scholar
• Lewis W, Simpson JF, Meyer RR Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine. Circ Res. 1994, 74, 344–348.
   PubMed Web of Science ®Google Scholar
• Lewis W, Day BJ, Copeland WC Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov. 2003, 2, 812–822.
   PubMed Web of Science ®Google Scholar
• Engelman A, Cherepanov P Retroviral integrase structure and DNA recombination mechanism. Microbiol Spectr. 2014, 2, 1–22.
   PubMedGoogle Scholar
• Maskell DP, Renault L, Serrao E, et al. Structural basis for retroviral integration into nucleosomes. Nature 2015, 523, 366–369.
   PubMed Web of Science ®Google Scholar
• Engelman A, Cherepanov P The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol. 2012, 10, 279–290.
   PubMed Web of Science ®Google Scholar
• Deng Z, Lehmann KC, Li X, et al. Structural basis for the regulatory function of a complex zinc-binding domain in a replicative arterivirus helicase resembling a nonsense-mediated mRNA decay helicase. Nucleic Acids Res. 2014, 42, 3464–3477.
   PubMed Web of Science ®Google Scholar
• Tang C, Deng Z, Li X, et al. Helicase of type 2 porcine reproductive and respiratory syndrome virus strain HV reveals a unique structure. Viruses 2020, 12. 12
   Web of Science ®Google Scholar
• Ruiz FX, Hoang A, Das K, et al. Structural basis of HIV-1 inhibition by nucleotide-competing reverse transcriptase inhibitor indopy-1. J Med Chem. 2019, 62, 9996–10002.
   PubMed Web of Science ®Google Scholar
• Singh K, Flores JA, Kirby KA, et al. Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors. Viruses 2014, 6, 3535–3562.
   PubMed Web of Science ®Google Scholar
• Das K, Bauman JD, Clark AD Jr., et al. High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. Proc Natl Acad Sci U S A 2008, 105, 1466–1471.
   PubMed Web of Science ®Google Scholar
• Janssen PA, Lewi PJ, Arnold E, et al. In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1e)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). J Med Chem. 2005, 48, 1901–1909.
   PubMed Web of Science ®Google Scholar
• Singh K, Marchand B, Rai DK, et al. Biochemical mechanism of HIV-1 resistance to rilpivirine. J Biol Chem. 2012, 287, 38110–38123.
   PubMed Web of Science ®Google Scholar
• Haggblom A, Svedhem V, Singh K, et al. Virological failure in patients with HIV-1 subtype c receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden. Lancet HIV 2016, 3, e166–174.
   PubMed Web of Science ®Google Scholar
• van Domselaar R, Njenda DT, Rao R, et al. HIV-1 subtype C with PYxE insertion has enhanced binding of Gag-p6 to host cell protein ALIX and increased replication fitness. J Virol. 2019, 93. 93
   Web of Science ®Google Scholar
• Kannan SR, Spratt AN, Quinn TP, et al. Infectivity of SARS-CoV-2: there is something more than D614G? J Neuroimmune Pharmacol. 2020. 15 574–577
   PubMed Web of Science ®Google Scholar